nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—SLCO2B1—Rifampicin—leprosy	0.286	0.318	CbGbCtD
Montelukast—CYP2A6—Rifampicin—leprosy	0.127	0.141	CbGbCtD
Montelukast—PTGS1—Thalidomide—leprosy	0.112	0.124	CbGbCtD
Montelukast—PTGS1—Dapsone—leprosy	0.0895	0.0995	CbGbCtD
Montelukast—CYP2C8—Rifampicin—leprosy	0.0626	0.0695	CbGbCtD
Montelukast—CYP2C8—Dapsone—leprosy	0.0516	0.0574	CbGbCtD
Montelukast—CYP2C9—Thalidomide—leprosy	0.0451	0.0501	CbGbCtD
Montelukast—CYP2C9—Rifampicin—leprosy	0.0436	0.0485	CbGbCtD
Montelukast—CYP2C9—Dapsone—leprosy	0.036	0.04	CbGbCtD
Montelukast—CYP3A4—Rifampicin—leprosy	0.0254	0.0282	CbGbCtD
Montelukast—CYP3A4—Dapsone—leprosy	0.0209	0.0233	CbGbCtD
Montelukast—Pulmonary eosinophilia—Dapsone—leprosy	0.0141	0.141	CcSEcCtD
Montelukast—Enuresis—Thalidomide—leprosy	0.00461	0.046	CcSEcCtD
Montelukast—Suicide attempt—Dapsone—leprosy	0.00454	0.0453	CcSEcCtD
Montelukast—Pyuria—Thalidomide—leprosy	0.00377	0.0376	CcSEcCtD
Montelukast—Erythema nodosum—Thalidomide—leprosy	0.00305	0.0304	CcSEcCtD
Montelukast—Hostility—Thalidomide—leprosy	0.00238	0.0237	CcSEcCtD
Montelukast—Foetor hepaticus—Thalidomide—leprosy	0.00232	0.0232	CcSEcCtD
Montelukast—Suicide attempt—Thalidomide—leprosy	0.00232	0.0232	CcSEcCtD
Montelukast—Liver disorder—Thalidomide—leprosy	0.00193	0.0193	CcSEcCtD
Montelukast—Nasopharyngitis—Dapsone—leprosy	0.00167	0.0167	CcSEcCtD
Montelukast—Influenza—Dapsone—leprosy	0.00162	0.0161	CcSEcCtD
Montelukast—Pancreatitis—Dapsone—leprosy	0.00158	0.0158	CcSEcCtD
Montelukast—Bone disorder—Thalidomide—leprosy	0.00146	0.0146	CcSEcCtD
Montelukast—Viral infection—Thalidomide—leprosy	0.00146	0.0146	CcSEcCtD
Montelukast—Neuropathy peripheral—Dapsone—leprosy	0.00141	0.0141	CcSEcCtD
Montelukast—Sinusitis—Dapsone—leprosy	0.00135	0.0135	CcSEcCtD
Montelukast—Hepatocellular injury—Thalidomide—leprosy	0.00132	0.0131	CcSEcCtD
Montelukast—Pharyngitis—Dapsone—leprosy	0.00128	0.0128	CcSEcCtD
Montelukast—Neuropathy—Thalidomide—leprosy	0.00124	0.0123	CcSEcCtD
Montelukast—Hyperkinesia—Thalidomide—leprosy	0.00115	0.0115	CcSEcCtD
Montelukast—Gastroenteritis—Thalidomide—leprosy	0.00108	0.0108	CcSEcCtD
Montelukast—Eczema—Thalidomide—leprosy	0.00106	0.0106	CcSEcCtD
Montelukast—Injury—Thalidomide—leprosy	0.00104	0.0104	CcSEcCtD
Montelukast—Cough—Dapsone—leprosy	0.000982	0.0098	CcSEcCtD
Montelukast—Cramp muscle—Thalidomide—leprosy	0.000861	0.00859	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000861	0.00859	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000861	0.00859	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Thalidomide—leprosy	0.000844	0.00842	CcSEcCtD
Montelukast—Insomnia—Dapsone—leprosy	0.000831	0.00829	CcSEcCtD
Montelukast—Influenza—Thalidomide—leprosy	0.000827	0.00825	CcSEcCtD
Montelukast—Eosinophilia—Thalidomide—leprosy	0.000819	0.00817	CcSEcCtD
Montelukast—Pancreatitis—Thalidomide—leprosy	0.000811	0.00809	CcSEcCtD
Montelukast—Bronchitis—Thalidomide—leprosy	0.000795	0.00793	CcSEcCtD
Montelukast—Upper respiratory tract infection—Thalidomide—leprosy	0.000768	0.00767	CcSEcCtD
Montelukast—Gastrointestinal pain—Dapsone—leprosy	0.000751	0.00749	CcSEcCtD
Montelukast—Pneumonia—Thalidomide—leprosy	0.000742	0.0074	CcSEcCtD
Montelukast—Infestation NOS—Thalidomide—leprosy	0.000737	0.00735	CcSEcCtD
Montelukast—Infestation—Thalidomide—leprosy	0.000737	0.00735	CcSEcCtD
Montelukast—Drowsiness—Thalidomide—leprosy	0.000737	0.00735	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000731	0.00729	CcSEcCtD
Montelukast—Abdominal pain—Dapsone—leprosy	0.000726	0.00724	CcSEcCtD
Montelukast—Body temperature increased—Dapsone—leprosy	0.000726	0.00724	CcSEcCtD
Montelukast—Neuropathy peripheral—Thalidomide—leprosy	0.000723	0.00721	CcSEcCtD
Montelukast—Conjunctivitis—Thalidomide—leprosy	0.000717	0.00715	CcSEcCtD
Montelukast—Epistaxis—Thalidomide—leprosy	0.000695	0.00694	CcSEcCtD
Montelukast—Sinusitis—Thalidomide—leprosy	0.000692	0.0069	CcSEcCtD
Montelukast—Rhinitis—Thalidomide—leprosy	0.000664	0.00662	CcSEcCtD
Montelukast—Hepatitis—Thalidomide—leprosy	0.000662	0.0066	CcSEcCtD
Montelukast—Hypoaesthesia—Thalidomide—leprosy	0.000659	0.00657	CcSEcCtD
Montelukast—Pharyngitis—Thalidomide—leprosy	0.000657	0.00655	CcSEcCtD
Montelukast—Urinary tract disorder—Thalidomide—leprosy	0.000654	0.00652	CcSEcCtD
Montelukast—Urethral disorder—Thalidomide—leprosy	0.000649	0.00647	CcSEcCtD
Montelukast—Erythema multiforme—Thalidomide—leprosy	0.000626	0.00624	CcSEcCtD
Montelukast—Cardiac disorder—Thalidomide—leprosy	0.000614	0.00613	CcSEcCtD
Montelukast—Immune system disorder—Thalidomide—leprosy	0.000598	0.00596	CcSEcCtD
Montelukast—Mediastinal disorder—Thalidomide—leprosy	0.000596	0.00595	CcSEcCtD
Montelukast—Vomiting—Dapsone—leprosy	0.000584	0.00583	CcSEcCtD
Montelukast—Mental disorder—Thalidomide—leprosy	0.00058	0.00578	CcSEcCtD
Montelukast—Headache—Dapsone—leprosy	0.000575	0.00574	CcSEcCtD
Montelukast—Muscle spasms—Thalidomide—leprosy	0.000554	0.00553	CcSEcCtD
Montelukast—Nausea—Dapsone—leprosy	0.000546	0.00544	CcSEcCtD
Montelukast—Tremor—Thalidomide—leprosy	0.00054	0.00538	CcSEcCtD
Montelukast—Agitation—Thalidomide—leprosy	0.000529	0.00528	CcSEcCtD
Montelukast—Angioedema—Thalidomide—leprosy	0.000526	0.00525	CcSEcCtD
Montelukast—Palpitations—Thalidomide—leprosy	0.000509	0.00508	CcSEcCtD
Montelukast—Cough—Thalidomide—leprosy	0.000503	0.00501	CcSEcCtD
Montelukast—Convulsion—Thalidomide—leprosy	0.000499	0.00498	CcSEcCtD
Montelukast—Arthralgia—Thalidomide—leprosy	0.00049	0.00489	CcSEcCtD
Montelukast—Myalgia—Thalidomide—leprosy	0.00049	0.00489	CcSEcCtD
Montelukast—Anxiety—Thalidomide—leprosy	0.000489	0.00488	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000487	0.00486	CcSEcCtD
Montelukast—Oedema—Thalidomide—leprosy	0.00047	0.00469	CcSEcCtD
Montelukast—Infection—Thalidomide—leprosy	0.000467	0.00466	CcSEcCtD
Montelukast—Nervous system disorder—Thalidomide—leprosy	0.000461	0.0046	CcSEcCtD
Montelukast—Thrombocytopenia—Thalidomide—leprosy	0.00046	0.00459	CcSEcCtD
Montelukast—Skin disorder—Thalidomide—leprosy	0.000457	0.00456	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Thalidomide—leprosy	0.000428	0.00427	CcSEcCtD
Montelukast—Insomnia—Thalidomide—leprosy	0.000425	0.00424	CcSEcCtD
Montelukast—Paraesthesia—Thalidomide—leprosy	0.000422	0.00421	CcSEcCtD
Montelukast—Somnolence—Thalidomide—leprosy	0.000418	0.00417	CcSEcCtD
Montelukast—Dyspepsia—Thalidomide—leprosy	0.000414	0.00413	CcSEcCtD
Montelukast—Gastrointestinal disorder—Thalidomide—leprosy	0.000406	0.00405	CcSEcCtD
Montelukast—Fatigue—Thalidomide—leprosy	0.000405	0.00404	CcSEcCtD
Montelukast—Pain—Thalidomide—leprosy	0.000402	0.00401	CcSEcCtD
Montelukast—Gastrointestinal pain—Thalidomide—leprosy	0.000384	0.00384	CcSEcCtD
Montelukast—Urticaria—Thalidomide—leprosy	0.000374	0.00373	CcSEcCtD
Montelukast—Body temperature increased—Thalidomide—leprosy	0.000372	0.00371	CcSEcCtD
Montelukast—Abdominal pain—Thalidomide—leprosy	0.000372	0.00371	CcSEcCtD
Montelukast—Hypersensitivity—Thalidomide—leprosy	0.000346	0.00346	CcSEcCtD
Montelukast—Asthenia—Thalidomide—leprosy	0.000337	0.00337	CcSEcCtD
Montelukast—Pruritus—Thalidomide—leprosy	0.000333	0.00332	CcSEcCtD
Montelukast—Diarrhoea—Thalidomide—leprosy	0.000322	0.00321	CcSEcCtD
Montelukast—Dizziness—Thalidomide—leprosy	0.000311	0.0031	CcSEcCtD
Montelukast—Vomiting—Thalidomide—leprosy	0.000299	0.00298	CcSEcCtD
Montelukast—Rash—Thalidomide—leprosy	0.000296	0.00296	CcSEcCtD
Montelukast—Dermatitis—Thalidomide—leprosy	0.000296	0.00295	CcSEcCtD
Montelukast—Headache—Thalidomide—leprosy	0.000295	0.00294	CcSEcCtD
Montelukast—Nausea—Thalidomide—leprosy	0.000279	0.00279	CcSEcCtD
